Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

The Global Urology Devices Market is Predicted to Exhibit Remarkable Growth at CAGR of ~7% by 2027 | DelveInsight

Published

on

New York, USA, Jan. 24, 2023 (GLOBE NEWSWIRE) — The Global Urology Devices Market is Predicted to Exhibit Remarkable Growth at CAGR of ~7% by 2027 | DelveInsight

The urology devices market is experiencing a surge in product demand due to a variety of factors, including an aging population that is susceptible to developing various age-related indications such as benign prostatic hyperplasia in older men, an increase in the prevalence of kidney disorders such as kidney stones, and an increase in the prevalence of lifestyle disorders such as hypertension and diabetes, which may have an impact on the health of older men.

DelveInsight’s Urology Devices Market Insights report provides the current and forecast market analysis, individual leading urology devices companies’ market shares, challenges, urology devices market drivers, barriers, and trends, and key urology devices companies in the market.

Key Takeaways from the Urology Devices Market Report

  • As per DelveInsight estimates, North America is anticipated to dominate the global urology devices market during the forecast period. 
  • Notable urology devices companies such as Olympus, Baxter, Boston Scientific Corporation, Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Medtronic, Cook, BestMedical, Potent Medical, Laborie, Well Lead Medical Co., Ltd, Amecath Medical Technologies, NIKKISO CO., LTD, Asahi Kasei Medical, Applied Medical Resources Corporation,  Advin Urology, DirexGroup, STORZ MEDICAL AG Richard Wolf GmbH, and several others are currently operating in the urology devices market.
  • In September 2022, Advanced MedTech Holdings announced the purchase of a majority stake in WIKKON, the Chinese market leader in urology and shock wave therapy devices.
  • In May 2022, the Johnson & Johnson subsidiary announced that its Monarch robotic surgery system had received a second FDA clearance, allowing it to be used in kidney stone removal procedures.
  • In May 2022, OmniGuide Holdings (OGH) announced that the US Food and Drug Administration approved RevoLixTM HTL, a family of pulsed and continuous wave Thulium YAG lasers that serves as the foundation of RevoLix Therapy for urology patients undergoing BPH and Stone Management procedures.
  • In January 2022, Applaud Medical, Inc received the Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The Acoustic Enhancer technology is designed to be used in conjunction with Ureteroscopy with Laser Lithotripsy (URS-LL).
  • In January 2021, the US Food and Drug Administration granted regulatory approval to Quanta Dialysis Technologies Ltd for their product- the hemodialysis system SC+. The device is a portable system that is capable of offering dialysis care comparable to full-sized dialysis equipment in a range of care settings.

To read more about the latest highlights related to the urology devices market, get a snapshot of the key highlights entailed in the Global Urology Devices Market Report

Urology Devices Overview

Urology devices encompass a wide range of devices used in the treatment of urogenital system indications. Urology devices aid in the diagnosis and treatment of a wide range of urological disorders, including urolithiasis, urethral malignancies, bladder disorders, and kidney diseases. Catheters, dilators, and sheaths are examples of consumables. Urodynamic systems, urology robotic systems, laser, and lithotropsy devices, cystoscopes, and ureteroscopes are among the devices used to diagnose bladder and urethral disorders.

Urology Devices Market Insights

North America is expected to account for the largest share of the urology devices market among all regions. This dominance is due to the rising prevalence of urinary tract cancers and an increasing population of patients suffering from lifestyle disorders such as obesity and hypertension, both of which play a role in the development of urogenital diseases. Furthermore, extensive product development efforts and the growing popularity of home-based dialysis devices are expected to drive product demand in the North American region. In addition to the factors mentioned above, new product launches and approvals and extensive coverage of procedural costs are expected to boost the urology devices market in North America.

To know more about why North America is leading the market growth in the urology devices market, get a snapshot of the Urology Devices Market Outlook 

Urology Devices Market Dynamics

The growing geriatric population is one of the key factors driving the urology devices market. The rising prevalence of chronic kidney disorders is another significant factor driving up product demand in the urology devices market. This can be attributed to the global rise in diabetes prevalence.

However, limitations associated with specific devices and high capital investments for certain devices may deter the growth of the urology devices market.

Aside from the factors mentioned above, the urology devices market was impacted by the COVID-19 pandemic lockdown. Because this urology devices market is highly diverse in terms of product type, the impact of the pandemic may vary depending on the product type. For example, while there was a slight decrease in dialysis services due to the critical nature of such procedures in terms of supporting life, the trends worldwide varied greatly. 

However, procedures classified as elective experienced a decrease in product demand and procedure completion. Nonetheless, the post-pandemic scenario provides a suitable environment for revenue generation for the urology devices market due to the resumption of full-capacity activities, thereby improving the market outlook for the urology devices market during the forecast period.

Get a sneak peek at the urology devices market dynamics @ Urology Devices Market Dynamics Analysis

Report Metrics Details
Coverage Global
Study Period 2019–2027
Base Year 2021
Urology Devices Market CAGR ~7%
Projected Urology Devices Market Size by 2027 USD 13.56 Billion
Key Urology Devices Companies Olympus, Baxter, Boston Scientific Corporation, Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Medtronic, Cook, BestMedical, Potent Medical, Laborie, Well Lead Medical Co., Ltd, Amecath Medical Technologies, NIKKISO CO., LTD, Asahi Kasei Medical, Applied Medical Resources Corporation,  Advin Urology, DirexGroup, STORZ MEDICAL AG Richard Wolf GmbH, among others

Urology Devices Market Assessment

  • Urology Devices Market Segmentation
    • Market Segmentation By Product: Dialysis Devices, Endoscopes (Ureteroscopes, Nephroscopes, Resectoscopes, And Others), Uroodynamic Systems, Lithotripters, Biopsy Devices, Uretral Stents, and Others
    • Market Segmentation By End User: Hospitals, Specialty Clinics, and Others
    • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the urology devices market are set to emerge as the trendsetter explore @ Urology Devices Companies 

Table of Contents 

1 Report Introduction
2 Executive summary
3 Regulatory and Patent Analysis
4 Key Factors Analysis
5 Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Urology Devices Market
7 Urology Devices Market Layout
8 Global Company Share Analysis – Key 3-5 Companies
9 Urology Devices Market Company and Product Profiles
10 Project Approach
11 About DelveInsight

Interested in knowing the urology devices market by 2027? Click to get a snapshot of the Urology Devices Market Trends

Related Reports

Urolithiasis Market

Urolithiasis Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key urolithiasis companies, including Alnylam Pharmaceuticals, Astellas Pharma, OptMed, among others.

Urology Lasers Market

Urology Lasers Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key urology lasers companies, including Olympus Corporation, Stryker Corporation, Boston Scientific Corporation, among others.

Urology Catheters Market

Urology Catheters Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key urology catheters companies, including Amecath Medical Technologies, Teleflex Incorporated, Elreda, COOK, among others.

Urology Ultrasounds Market

Urology Ultrasounds Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key urology ultrasounds companies, including General Electric Company (GE Healthcare), ESAOTE SPA, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., BK Medical Holding Company, Inc., among others.

Acute Kidney Injury Market

Acute Kidney Injury Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key acute kidney injury companies, including Alloksys, Vifor Pharma, Exponential Biotherapies, Astellas Pharma, Pharming Technologies, among others.

Diabetic Kidney Disease Pipeline

Diabetic Kidney Disease Pipeline Insight – 2023 report provides comprehensive insights about pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key diabetic kidney disease companies, including Gilead Sciences, Kyowa Kirin, Bayer, among others.

Other Trending Reports

Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.  


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading
Advertisement

Latest News

Trending